Latest Insider Transactions at Checkpoint Therapeutics, Inc. (CKPT)
This section provides a real-time view of insider transactions for Checkpoint Therapeutics, Inc. (CKPT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Checkpoint Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Checkpoint Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 01
2023
|
William Garrett Gray Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,154
-6.0%
|
$12,616
$4.79 P/Share
|
|
Jan 10
2023
|
James F Oliviero Iii CEO, President and Director |
SELL
Open market or private sale
|
Direct |
3,817
-1.95%
|
$22,902
$6.75 P/Share
|
|
Jan 10
2023
|
William Garrett Gray Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,858
-3.42%
|
$11,148
$6.75 P/Share
|
|
Jan 05
2023
|
Fortress Biotech, Inc. |
BUY
Grant, award, or other acquisition
|
Direct |
368,907
+19.7%
|
-
|
|
Jun 23
2022
|
James F Oliviero Iii CEO, President and Director |
SELL
Open market or private sale
|
Direct |
15,000
-0.58%
|
$15,000
$1.11 P/Share
|
|
Jun 22
2022
|
James F Oliviero Iii CEO, President and Director |
SELL
Open market or private sale
|
Direct |
12,000
-0.46%
|
$12,000
$1.09 P/Share
|
|
Jun 21
2022
|
James F Oliviero Iii CEO, President and Director |
SELL
Open market or private sale
|
Direct |
21,000
-0.8%
|
$21,000
$1.09 P/Share
|
|
Jun 17
2022
|
James F Oliviero Iii CEO, President and Director |
SELL
Open market or private sale
|
Direct |
228,000
-8.03%
|
$228,000
$1.09 P/Share
|
|
Jun 16
2022
|
Michael S Weiss Director |
BUY
Grant, award, or other acquisition
|
Indirect |
47,619
+27.36%
|
-
|
|
Jun 16
2022
|
Barry M Salzman Director |
BUY
Grant, award, or other acquisition
|
Direct |
47,619
+21.26%
|
-
|
|
Jun 16
2022
|
Lindsay A Md Rosenwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
47,619
+12.73%
|
-
|
|
Jun 16
2022
|
Neil Herskowitz Director |
BUY
Grant, award, or other acquisition
|
Direct |
47,619
+21.26%
|
-
|
|
Jun 16
2022
|
Scott Boilen Director |
BUY
Grant, award, or other acquisition
|
Direct |
47,619
+19.34%
|
-
|
|
Jun 16
2022
|
Christian Bechon Director |
BUY
Grant, award, or other acquisition
|
Direct |
47,619
+24.1%
|
-
|
|
Apr 13
2022
|
James F Oliviero Iii CEO, President and Director |
SELL
Open market or private sale
|
Direct |
21,258
-0.74%
|
$21,258
$1.51 P/Share
|
|
Apr 05
2022
|
James F Oliviero Iii CEO, President and Director |
SELL
Open market or private sale
|
Direct |
14,030
-0.49%
|
$14,030
$1.77 P/Share
|
|
Apr 04
2022
|
James F Oliviero Iii CEO, President and Director |
SELL
Open market or private sale
|
Direct |
86,353
-2.92%
|
$86,353
$1.79 P/Share
|
|
Mar 10
2022
|
William Garrett Gray Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
38,197
-6.56%
|
$38,197
$1.89 P/Share
|
|
Feb 24
2022
|
James F Oliviero Iii CEO, President and Director |
SELL
Payment of exercise price or tax liability
|
Direct |
117,657
-3.82%
|
$117,657
$1.85 P/Share
|
|
Feb 01
2022
|
William Garrett Gray Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
37,063
-5.99%
|
$74,126
$2.51 P/Share
|
|
Jan 31
2022
|
James F Oliviero Iii CEO, President and Director |
BUY
Grant, award, or other acquisition
|
Direct |
455,000
+11.2%
|
-
|
|
Jan 31
2022
|
William Garrett Gray Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
137,000
+18.12%
|
-
|
|
Jan 30
2022
|
James F Oliviero Iii CEO, President and Director |
SELL
Payment of exercise price or tax liability
|
Direct |
31,972
-1.03%
|
$63,944
$2.46 P/Share
|
|
Jan 24
2022
|
James F Oliviero Iii CEO, President and Director |
SELL
Payment of exercise price or tax liability
|
Direct |
143,136
-4.4%
|
$286,272
$2.19 P/Share
|
|
Jan 06
2022
|
James F Oliviero Iii CEO, President and Director |
SELL
Payment of exercise price or tax liability
|
Direct |
53,024
-1.6%
|
$106,048
$2.77 P/Share
|
|
Jan 01
2022
|
James F Oliviero Iii CEO, President and Director |
SELL
Payment of exercise price or tax liability
|
Direct |
302,777
-8.39%
|
$908,331
$3.11 P/Share
|
|
Jun 10
2021
|
Christian Bechon Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,502
+13.89%
|
-
|
|
Jun 10
2021
|
Neil Herskowitz Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,502
+11.36%
|
-
|
|
Jun 10
2021
|
Lindsay A Md Rosenwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,502
+5.59%
|
-
|
|
Jun 10
2021
|
Barry M Salzman Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,502
+11.36%
|
-
|
|
Jun 10
2021
|
Michael S Weiss Director |
BUY
Grant, award, or other acquisition
|
Indirect |
16,502
+17.32%
|
-
|
|
Jun 10
2021
|
Scott Boilen Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,502
+9.85%
|
-
|
|
Feb 05
2021
|
James F Oliviero Iii CEO, President and Director |
SELL
Open market or private sale
|
Direct |
48,790
-1.52%
|
$146,370
$3.42 P/Share
|
|
Feb 04
2021
|
William Garrett Gray Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
26,320
-5.18%
|
$78,960
$3.66 P/Share
|
|
Feb 04
2021
|
James F Oliviero Iii CEO, President and Director |
SELL
Open market or private sale
|
Direct |
70,000
-2.14%
|
$210,000
$3.51 P/Share
|
|
Jan 06
2021
|
William Garrett Gray Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
151,000
+22.9%
|
-
|
|
Jan 06
2021
|
James F Oliviero Iii CEO, President and Director |
BUY
Grant, award, or other acquisition
|
Direct |
539,000
+14.14%
|
-
|
|
Dec 22
2020
|
William Garrett Gray Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,406
-0.67%
|
$4,812
$2.79 P/Share
|